The impact of the new sexual pharmaceuticals on sex therapy

摘要: Since the March 27, 1998 introduction of sildenafil, opportunities for sex therapists have expanded, primarily in three ways: 1) public education, 2) colleague and 3) treatment. Primary care physicians urologists learned that incorporating therapy techniques improved effectiveness sildenafil; furthermore, discovered integrating adjunctive use sildenafil with accelerated process outcome. As new pharmaceuticals are developed approved men women, medical nonmedical will only increase. In fact, playing an increasingly important consultative role to industry research development sexual pharmaceuticals. However, optimism nonphysician is tempered by recognition continuing trend toward medicalization dysfunction.